Catalyst Pharmaceutical Partners Inc. | Key People and Executives
Patrick J. McEnany
Chairman, President & Chief Executive Officer
David S. Tierney
Independent Director
Charles B. O'Keeffe
Lead Independent Director
Philip H. Coelho
Independent Director
Donald A. Denkhaus
Independent Director
Richard J. Daly
Independent Director
Patrick J. McEnany
Chairman, President & Chief Executive Officer
Steven R. Miller
Chief Operating & Scientific Officer
Alicia Grande
Chief Financial Officer, Treasurer & VP
Gary Ingenito
Chief Medical Officer & Head-Regulatory Affairs
Stanley Iyadurai
Vice President-Clinical Development
Maria Pandolfo
Senior Director-Patient Services
Jason James
Senior VP-Commercial Operations & Analytics
Daniel Brennan
Chief Commercial Officer
David J. Caponera
VP-Patient Engagement & Access Support
Brian Elsbernd
Senior Vice President-Legal & Compliance
Jeff Del Carmen
Senior Vice President-Sales & Marketing
David S. Tierney
Independent Director
Charles B. O'Keeffe
Lead Independent Director
Philip H. Coelho
Independent Director
Donald A. Denkhaus
Independent Director
Richard J. Daly
Independent Director
| Address |
355 Alhambra Circle
Coral Gables Florida 33134
United States
|
|
Employees
|
- |
| Website |
http://www.catalystpharma.com |
| Updated |
07/08/2019 |
| Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder. The company was founded by McEnany J. |
